Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07301749

A Clinical Study Evaluating the Safety and Efficacy of the VCFix Spinal System for Treatment of Vertebral Compression Fractures.

A Prospective Multicenter Clinical Investigation Evaluating the Safety and Efficacy of the VCFix Spinal System in Stand-alone Configuration for Vertebral Augmentation (EXPAND)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
103 (estimated)
Sponsor
Amber Implants B.V. · Industry
Sex
All
Age
21 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The primary objective of the EXPAND clinical investigation is to evaluate the safety and efficacy of the VCFix Spinal System for the treatment of Vertebral Compression Fractures. The study aims to demonstrate a reduction in vertebral fracture-related pain and an improvement in physical function and mobility, while ensuring the absence of (serious) adverse events ((S)AE) related to the device or procedure.

Conditions

Interventions

TypeNameDescription
DEVICEVCFix Spinal System in stand-alone configurationThe distinguishing features of this inetrvention reside in: 1. In situ adjustment and maintenance of the height and angle of the device that allows expansion of the fractured VB in the cranio-caudal direction to realign the vertebral endplates and correct kyphosis. 2. The complex titanium perforated structure with optimized surface roughness that allows possible bone attachment, thereby permitting natural healing of the bone and potentially providing more stability to the device and the treated vertebra over time. 3. The ability to likely secure and reinforce the vertebra without using PMMA bone cement, avoiding all the symptomatic and asymptomatic side effects of bone cement. 4. The ability to connect the posterior to the anterior column of the spine through the pedicle screw component of the VCFix implant, therefore improving the biomechanical load distribution and consequently the ability to stabilize more severe fractures.

Timeline

Start date
2025-11-04
Primary completion
2027-07-31
Completion
2028-12-31
First posted
2025-12-24
Last updated
2025-12-24

Locations

3 sites across 2 countries: France, Germany

Source: ClinicalTrials.gov record NCT07301749. Inclusion in this directory is not an endorsement.